First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer
by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of
Updated on: January 04,2024
8
First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer
by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of
Updated on:January 04,2024
8
